Schedule 13D ownership disclosure
SCICLONE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 80862K104
Event date: 2016-11-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-133591
- Form type
- SC 13D
- Filer
- GL Partners Capital Management Ltd
- CIK
- CIK 1562291
- Filed
- Nov 14, 2016
- Reporting period
- Nov 14, 2016
- Description
- Schedule 13D beneficial ownership